Additionally, an increasing trend of CROs has been reported, ranging from 8.3% in 2017 to 35.2% in 2022, posing a substantial challenge in patient management [ 17 , 18 , 19 , 20 , 21 ].
← all excerpts
Multiplex PCR-Based Detection of Eight Carbapenemase Genes and Their Clinical Characteristics in Urinary Tract Infections
1
—
—